RecruitingNot ApplicableNCT05188183

Pragmatic Trial of Remote tDCS and Somatosensory Training for Phantom Limb Pain With Machine Learning to Predict Treatment Response


Sponsor

Spaulding Rehabilitation Hospital

Enrollment

290 participants

Start Date

Sep 1, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The investigators have designed a pragmatic trial of home-based transcranial direct current stimulation (tDCS) for phantom limb pain (PLP), the PLP-EVEREST trial (PLP-EffectiVEness pRagmatic Stimulation Trial) to test a portable device that would reach underrepresented populations and would validate this therapy in a more pragmatic setting. Subjects will be randomized to home-based tDCS of the primary motor cortex (M1) with somatosensory training or usual care only (including their current pharmacological treatments, physical therapy, and occupational therapy). The investigators will therefore test the effectiveness of home-based tDCS and somatosensory training in a real-world, home-based setting. The Investigator will compare patients randomized to this combined strategy vs. usual care alone (subjects from this group will be offered combined treatment at the end of the trial). The investigators hypothesize that the combined strategy will be associated with a significantly larger Cohen's d effect size (at least 1) compared to the control group.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Age - older than 18 years
  • Limb amputation
  • Patients who experience PLP regularly (at least once a week)
  • Pain not attributable to other causes, such as peripheral inflammation
  • Current chronic pain as defined by an average pain of at least 4 on the numeric rating scale (NRS, 0: no pain, 10: worst imaginable pain)

Exclusion Criteria6

  • Any clinically significant or unstable medical or psychiatric disorder
  • History of substance abuse in the past 6 months (according to the DSM-V criteria for substance use disorder with six or more symptoms)
  • Uncompensated psychiatric disorder
  • Previous significant neurological history with current significant neurological deficits
  • Previous neurosurgical procedure with craniectomy that would affect current distribution of tDCS
  • Contraindications to tDCS (implanted brain medical devices)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEM1 anodal home-based tDCS

During tDCS, low amplitude direct currents are applied via scalp electrodes and penetrate the skull to enter the brain. Direct current will be transferred by a saline-soaked pair of surface sponge electrodes (35 cm2) and delivered by a specially developed, battery-driven, constant current stimulator with a maximum output of 10 mA.

BEHAVIORALSomatosensory Training

The somatosensory training will be performed during the self-administration of tDCS, including 20 sessions over 4 weeks. Sessions will start with relaxation exercises using a body scan technique, whereby subjects in a relaxed state will be instructed to sequentially interchange their mind to different regions of the body while perceiving it and establishing contact with the body part. Subjects will be asked to concentrate on any feeling (kinetic, kinesthetic or exteroceptive) related to each body part. Phantom exercises will involve the use of imagined movements of the phantom limb. Therefore, patients will be asked to perform general exercises with their phantom limb. Exercises will include hip, knee, ankle, and toe movements.

OTHERUsual Care

Usual care includes pharmacological treatments, physical therapy, occupational therapy and/or behavioral therapy that the subject is receiving.


Locations(1)

Spaulding Hospital Cambridge

Cambridge, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05188183


Related Trials